跳至主要内容
临床试验/CTRI/2018/02/011926
CTRI/2018/02/011926招募中未知

A randomized double blind study of prophylactic Levetiracetam for the prevention of post stroke seizures(PROLEVIS)- Investigator initiated academic trial - PROLEVIS

Department of Science and Technology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with either ischemic stroke (arterial or venous occlusion) or parenchymal intracerebral haemorrhage (spontaneous non-aneurysmal, non-traumatic intracerebral haemorrhage) with a cortical syndrome (either parenchymal involvement documented by imaging (CT/MRI) or presence of seizures, aphasia, apraxia or agnosia)
  • 2. Presenting within 1 week of onset in arterial stroke and within 2 weeks of confirmation of ICVT.

排除标准

  • 1. Previous history of epilepsy or treatment with an AED
  • 2. Life expectation less than 1 month due to stroke or other life-threatening comorbidity
  • 3. Subarachnoid or intraventricular hemorrhage
  • 4. Isolated posterior circulation stroke involving brainstem or cerebellum
  • 5. ICVT without cortical syndrome (clinical or radiological)
  • 6. ICH due to brain tumor, trauma, vascular malformation, brain surgery or infection
  • 7. Pre-existing dementia
  • 8. Known allergy to Levieracetam

研究者

相似试验